News Tag: research results

NRG Oncology Study Determines Total Neoadjuvant Therapy with Pembrolizumab and Chemoradiotherapy is Safe, but May Not be Beneficial for Patients with Locally-Advanced Rectal Cancer

Read More

Follow Up Results on First Multicenter Trial to Report Outcomes of Salvage Low Dose Radiotherapy Brachytherapy after External Beam Radiotherapy for Prostate Cancer

Read More

NRG-RTOG 0617 Validates ERCC1/2 Genotypic Signature as a Radiosensitivity Biomarker for Tumor and Normal Tissues in Non-Small Cell Lung Cancer Patients

Read More

NRG Oncology Study on Treatment for Advanced Endometrial Cancer Chosen as ‘Editor’s Choice’ in Journal of Clinical Oncology

Read More

Updated Analysis of NRG-RTOG 9813 Indicates IDH1/2 Mutation Status is Statistically Associated with Better Overall and Progression-free Survival for Patients with Anaplastic Astrocytoma

Read More

Metastasis-Free Survival is a Strong Surrogate Endpoint for Overall Survival over Biochemical Failure for Men Receiving Salvage Radiotherapy for Recurrent Prostate Cancer

Read More

Updated Results of NRG Oncology Trial Display Effectiveness of Gemcitabine and Daily Radiation for Bladder Preservation in Muscle-Invasive Bladder Cancer Patients

Read More

NRG-BN001 Photon IMRT Treatment Group Displays No Significant Survival Difference Between Arms for Patients with Glioblastoma, Proton Treatment Group Still Accruing

Read More

Trastuzumab Combined with Trimodality Treatment Does Not Improve Outcomes for Patients with HER2-Overexpressing Esophageal Cancer on NRG Oncology Trial

Read More

MTX-based Chemotherapy Combined with Low-Dose, Whole-Brain Radiotherapy Improves Progression-free Survival for Patients with Newly Diagnosed CNS Lymphoma

Read More